Mark Sarlo is a Senior Scientist specializing in Clinical Safety and Risk Management in Oncology at Merck since 2022. They previously served as a Pharmacist in Drug Product Development at The Janssen Pharmaceutical Companies of Johnson & Johnson from 2020 to 2022 and completed a PGY1 Pharmacy Residency at New York-Presbyterian Hospital in 2020. Mark holds an M.B.A. from West Virginia University and is currently pursuing a Doctor of Pharmacy, a Master of Science in Pharmacology, and a Bachelor of Arts in Biological Sciences, all from various institutions.
Location
Philadelphia, United States
This person is not in any teams